EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities

Daniel Boakye, Charles Mackenzie iD, Jamie Tallant, Anne Heggen, Sashi Leff, Lokemla Nadjilar, Moussa Sow

PLOS Neglected Tropical Diseases · 13.07.2023 · 17 (7) · e0011348

DOI: 10.1371/journal.pntd.0011348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 13.07.2023. Verfasst von Daniel Boakye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reaching the Last Mile Fund, The END Fund, New York, New York, United States of America. Hauptthemen laut MEDLINE: Onchocerciasis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RLMF Consortium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding when it is the appropriate time to stop administering the drugs in a chemotherapy-centered treatment program such as onchocerciasis remains a challenge due to cost, imperfect testing procedures, and a lack of long-term experience. Different approaches for assessing when a program can begin the extensive stop-treatment surveys have been recommended, and tested, with varying results. We describe here a practical approach that is based on information on both transmission as well as infection. This new protocol first defines operational transmission zones (OTZs) based on vector breeding sites followed by an epidemiological assessment of the resident populations adjacent to these breeding sites. Basing decisions to stop MDA treatment based on breeding site locations (i.e., transmission zones) rather than on political administrative units, is a practical, cost-effective approach. Importantly, this biology-based approach is more closely related to the actual state of onchocerciasis transmission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OnchocerciasisHumansMass Drug AdministrationIvermectinCost-Effectiveness AnalysisHealth Facilities

Substanzen

Ivermectin

Autor:innen und Institutionen

  • Reaching the Last Mile Fund, The END Fund, New York, New York, United States of America.
  • Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
  • NTD Support Center, Task Force for Global Health, Decatur, Georgia, United States of America.
  • Onchocerciasis Elimination Program, Ministry of Health, Republic of Tchad.
  • Onchocerciasis Elimination Program, Ministry of Health, Republic of Mali.

ORCID-Profile: Charles Mackenzie

Förderung

  • RLMF Consortium

Zitieren

APA

Boakye, D., Mackenzie, C., Tallant, J., Heggen, A., Leff, S., Nadjilar, L., & Sow, M. (2023). Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities. PLOS Neglected Tropical Diseases, 17(7), e0011348. https://doi.org/10.1371/journal.pntd.0011348

Vancouver

Boakye D, Mackenzie C, Tallant J, Heggen A, Leff S, Nadjilar L, et al. Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities. PLOS Neglected Tropical Diseases. 2023;17(7):e0011348. doi:10.1371/journal.pntd.0011348

BibTeX
@article{Boakye2023,
  author = {Boakye, Daniel and Mackenzie, Charles and Tallant, Jamie and Heggen, Anne and Leff, Sashi and Nadjilar, Lokemla and Sow, Moussa},
  title = {Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  volume = {17},
  number = {7},
  pages = {e0011348},
  doi = {10.1371/journal.pntd.0011348}
}
Kostenlos starten →